Ashley Cordova, Chief Financial Officer at NovoCure Ltd (NVCR), sold 688 shares at $20.14 ($14K) on 2024-08-02, disclosed to the SEC on 2024-08-05.
Seasonal sale ($14k) by Chief Financial Officer — this insider has traded NVCR in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2025-03-03 | $452K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |
| NVCR | SELL | 2023-08-04 | $35K | — | Filing → |